कृपया अन्य खोज का प्रयास करें
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
John Horton | - | - | Director of Epichem Pty Ltd |
Rebecca McCrackan | - | 2016 | Director of Epichem Pty Ltd |
Robert Charles Bishop | - | 2013 | Executive Director |
Angela Frimberger | - | 2017 | Veterinary Clinical Advisory Board Chair |
Christian Schirvel | - | 2017 | Veterinary Clinical Advisory Board Member |
Barbara Kitchell | - | 2017 | Veterinary Advisory Board Member |
Marcus Paul Hughes | - | 2024 | Director |
Sergio Duchini | - | 2024 | Non-Executive Chairman |
John Clark | - | 2024 | Interim CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है